Disclosure 0001193125-26-377207-2

SEC FORM 4

$98,735.53

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 8,222 shares at $12.0087 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377207 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-08-31. https://desqlong.com/cards/0001193125-26-377207-2 (retrieved 2026-09-26).